The news: Prescription drugmakers spent $2.97 billion on national TV advertising in the first half of 2025, an increase of 12.2% YoY, per iSpot.tv.

Digging into the data: Pharma companies increased spending on linear TV media, primarily among those selling diabetes and weight loss drugs.

Diabetes and blood disorder drugmakers spent the most ($568.8 million) on linear TV ads. Four GLP-1 brands (Wegovy, Ozempic, Zepbound, and Mounjaro) accounted for $413.2 million of the total.
Psoriasis, shingles, and skin & nail prescription drugs were next with $430 million spent.
Bladder and gastrointestinal conditions accounted for third-highest spending at $392.5 million.

You've read 0 of 2 free articles this month.

Get more articles - create your free account today!

Products

Events & Resources

Topics

Latest Articles

Shoppers hate paying for return shipping more than any other part of the process

Doctors expect longer visits as parents seek clarity about pediatric vaccine guidelines

Lowe’s reaches out to Gen Alpha with new rewards program for kids

Meta faces critical questions as AI spending and regulatory scrutiny intensify

J&J launches direct-to-consumer prescription drug site with lower cash prices

The health and fitness industry’s future is subscription-first, not hardware-led

Scam exposure on social platforms threatens brands

Email is consumers’ top marketing channel, but inbox fatigue threatens ROI

How payment providers should react to OpenAI’s Instant Checkout walkback

Capital One joins finance industry layoff trend, sheds 1,100 Discover workers

About

Pharma spent almost $3 billion on TV advertising in the first six months

Coverage Areas →

Coverage Areas →

Advertising & Marketing

Health

Ecommerce & Retail

Technology

Financial Services

More Topics

Geographies

EMARKETER

Media Services

Free Content

Contact Us →

Worldwide HQ

Sales Inquiries